Nono Lydie Joëlle Seudjip, Simplice Konga Libeko, Luc Kalala Ntshila, Paulo Muntu Bunga, Georges Lelo Mvumbi, Pius Zakayi Kabututu, Marie José Bajani Kabedi, Tshimy Yona Tshimanga, Doudou Malekita Yobi, Marie-Pierre Hayette, Bive Bive Zono
{"title":"Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023.","authors":"Nono Lydie Joëlle Seudjip, Simplice Konga Libeko, Luc Kalala Ntshila, Paulo Muntu Bunga, Georges Lelo Mvumbi, Pius Zakayi Kabututu, Marie José Bajani Kabedi, Tshimy Yona Tshimanga, Doudou Malekita Yobi, Marie-Pierre Hayette, Bive Bive Zono","doi":"10.1111/myc.70010","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although cutaneous mycoses are a global public health problem, very few data are available in the Democratic Republic of Congo (DRC).</p><p><strong>Objectives: </strong>This study aimed to describe the retrospective clinical epidemiology of dermatomycosis and their associated risk factors in dermatological consultations in Kinshasa, DRC.</p><p><strong>Methods: </strong>A retrospective study based on the medical records of patients seen in the departments of dermatology of 2 major hospitals in Kinshasa from March 2000 to August 2023 was carried out. The diagnosis of the various types of dermatomycoses was established based on the dermatologist's clinical examination. Patient demographic and clinical data were collected for study purposes.</p><p><strong>Results: </strong>Of 27,439 patients consulted at the two sites, 1142 were diagnosed with dermatomycosis (4.16%). Young women aged 27 (17-43) were most affected. Diagnosed patients shared a history of skin mycoses (26%), use of skin-lightening products (19%) and diabetes mellitus (9.6%). Among these patients, 59.3% suffered from dermatophytosis (tinea), 39.1% from malassesiosis and 1.2% from candidal dermatosis. While tinea was predominantly found in children (81.88%, p < 0.001), pruritus and pain in the lesions were preferentially reported by the dermatophytosis patients [65.25% (p < 0.001) and 79.1% (p < 0.001), respectively]. Tinea corporis (45.5%), tinea capitis (20.4%), tinea pedis (19.3%) and onychomycosis (10.2%) were the main nosological entities in the dermatophytosis group, and their distribution on the body surface depended on patients' age (p < 0.001) and sex (p = 0.012).</p><p><strong>Conclusions: </strong>Dominated by dermatophytosis, dermatomycosis are frequent in dermatological consultations in Kinshasa. While clinical diagnosis remains an important element in the description of dermatomycosis, a better epidemiological understanding would also require biological identification of the fungi involved, which was lacking in this study.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 12","pages":"e70010"},"PeriodicalIF":4.1000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycoses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/myc.70010","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Although cutaneous mycoses are a global public health problem, very few data are available in the Democratic Republic of Congo (DRC).
Objectives: This study aimed to describe the retrospective clinical epidemiology of dermatomycosis and their associated risk factors in dermatological consultations in Kinshasa, DRC.
Methods: A retrospective study based on the medical records of patients seen in the departments of dermatology of 2 major hospitals in Kinshasa from March 2000 to August 2023 was carried out. The diagnosis of the various types of dermatomycoses was established based on the dermatologist's clinical examination. Patient demographic and clinical data were collected for study purposes.
Results: Of 27,439 patients consulted at the two sites, 1142 were diagnosed with dermatomycosis (4.16%). Young women aged 27 (17-43) were most affected. Diagnosed patients shared a history of skin mycoses (26%), use of skin-lightening products (19%) and diabetes mellitus (9.6%). Among these patients, 59.3% suffered from dermatophytosis (tinea), 39.1% from malassesiosis and 1.2% from candidal dermatosis. While tinea was predominantly found in children (81.88%, p < 0.001), pruritus and pain in the lesions were preferentially reported by the dermatophytosis patients [65.25% (p < 0.001) and 79.1% (p < 0.001), respectively]. Tinea corporis (45.5%), tinea capitis (20.4%), tinea pedis (19.3%) and onychomycosis (10.2%) were the main nosological entities in the dermatophytosis group, and their distribution on the body surface depended on patients' age (p < 0.001) and sex (p = 0.012).
Conclusions: Dominated by dermatophytosis, dermatomycosis are frequent in dermatological consultations in Kinshasa. While clinical diagnosis remains an important element in the description of dermatomycosis, a better epidemiological understanding would also require biological identification of the fungi involved, which was lacking in this study.
期刊介绍:
The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi.
Medical mycology as part of medical microbiology is advancing rapidly. Effective therapeutic strategies are already available in chemotherapy and are being further developed. Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research. Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress. The journal Mycoses is therefore of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.